Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
The price of Viridian Therapeutics Inc (NASDAQ: VRDN) closed at $15.53 in the last session, down -0.06% from day before closing price of $15.54. In other words, the price has decreased by -$0.06 from its previous closing price. On the day, 0.76 million shares were traded.
Ratios:
We take a closer look at VRDN’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 18.55 and its Current Ratio is at 18.55. In the meantime, Its Debt-to-Equity ratio is 0.03 whereas as Long-Term Debt/Eq ratio is at 0.03.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Wells Fargo on December 19, 2024, Downgraded its rating to Equal Weight and sets its target price to $27 from $37 previously.
Needham reiterated its Buy rating for the stock on September 11, 2024, while the target price for the stock was revised from $30 to $38.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Sep 27 ’24 when Beetham Thomas W. bought 5,000 shares for $23.41 per share. The transaction valued at 117,050 led to the insider holds 6,000 shares of the business.
Mahoney Stephen F. bought 21,400 shares of VRDN for $499,262 on Sep 27 ’24. The President and CEO now owns 21,400 shares after completing the transaction at $23.33 per share. On Sep 13 ’24, another insider, Fairmount Funds Management LLC, who serves as the Director of the company, bought 1,600,000 shares for $18.75 each. As a result, the insider paid 30,000,000 and bolstered with 3,445,813 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 4100.59 while its Price-to-Book (P/B) ratio in mrq is 2.37.
Stock Price History:
Over the past 52 weeks, VRDN has reached a high of $27.20, while it has fallen to a 52-week low of $11.40. The 50-Day Moving Average of the stock is -15.78%, while the 200-Day Moving Average is calculated to be -12.66%.
Shares Statistics:
A total of 79.18M shares are outstanding, with a floating share count of 71.23M. Insiders hold about 10.07% of the company’s shares, while institutions hold 105.28% stake in the company.
Earnings Estimates
Current recommendations for the stock of the company come from 12.0 analysts. The consensus estimate for the next quarter is -$1.04, with high estimates of -$0.84 and low estimates of -$1.3.
Analysts are recommending an EPS of between -$3.3 and -$4.19 for the fiscal current year, implying an average EPS of -$3.99. EPS for the following year is -$4.22, with 12.0 analysts recommending between -$3.17 and -$5.91.
Revenue Estimates
A total of 14 analysts have provided revenue estimates for VRDN’s current fiscal year. The highest revenue estimate was $1M, while the lowest revenue estimate was $200k, resulting in an average revenue estimate of $314.57k. In the same quarter a year ago, actual revenue was $314k
